The TWEAK/Fn14 signaling axis has been implicated in tumor growth and metastasis and therapeutic agents that target TWEAK or Fn14 are in development for potential use in cancer patients [1, 2, 16]. The gene discussed is TNFSF12; the disease is cancer.